CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Down 76.5% in December

CV Sciences, Inc. (OTCMKTS:CVSI) was the recipient of a significant decline in short interest during the month of December. As of December 31st, there was short interest totaling 60,091 shares, a decline of 76.5% from the December 15th total of 255,957 shares. Based on an average daily volume of 4,198,568 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 4,198,568 shares, the short-interest ratio is presently 0.0 days.

CV Sciences Price Performance

Shares of OTCMKTS CVSI opened at $0.05 on Tuesday. The stock’s 50-day moving average is $0.04 and its 200 day moving average is $0.04. CV Sciences has a 1-year low of $0.02 and a 1-year high of $0.10. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.21.

CV Sciences Company Profile

CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.